Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab with chemotherapy in untreated mantle cell lymphoma
NCT01144403Phase 2Terminated
- Sponsor
- Roche
- Start
- Jun 2010
- Primary completion
- Aug 2014
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab in mantle cell lymphoma (MCL), sponsored by Roche. Started Jun 2010; status: terminated.
02
Drugs
rituximab
03
Conditions
mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on NCT01144403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01144403.